Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

ENGR. H. B. NO. 1416 Page 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

ENGROSSED HOUSE
BILL NO. 1416 By: West (Josh) and Fugate of
the House

and

Rosino of the Senate

[ non-opioid treatment – preferred drug lists -
coverage - United States Food and Drug
Administration – reimbursement – codification -
effective date ]

BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 1313.1 of Title 74, unless there
is created a duplication in numbering, reads as follows:
A. As used in this section:
1. "Group insurance plan" means a group insurance plan that
covers state employees;
2. "Health care prescriber" means an individual authorized by
law to prescribe drugs;
3. "Insurer" means an insurer that offers a group insurance
plan; and

ENGR. H. B. NO. 1416 Page 2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

4. "Non-opioid treatment" means a drug or biological product
that is indicated to produce analgesia without acting on the body's
opioid receptors, for which there is no other drug or product that
is rated as therapeutically equivalent under the Food and Drug
Administration's most recent publication of "Approved Drug Products
with Therapeutic Equivalence Evaluations".
B. Except as otherwise provided in this section, an insurer,
for purposes of offering a group insurance plan, may adopt or amend
a state preferred drug list (PDL).
C. 1. In establishing and maintaining the PDL, the insurer
shall ensure that a non-opioid drug approved by the United States
Food and Drug Administration for the treatment or management of pain
is not disadvantaged or discouraged with respect to coverage
relative to an opioid or narcotic drug for the treatment or
management of pain on the PDL.
2. Paragraph 1 of this subsection does not prohibit an opioid
medication from being preferred over other opioid medications, or a
non-opioid medication from being preferred over other non-opioid
medications.
D. This section applies to a non-opioid treatment as defined in
paragraph 4 of subsection A of this section that has been reviewed
and approved for coverage by a group insurance plan or insurer as
defined in subsection A of this section. This section also applies

ENGR. H. B. NO. 1416 Page 3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

to drugs being provided under a contract between the insurer and a
pharmacy benefits manager for purposes of a group insurance plan.
SECTION 2. This act shall become effective November 1, 2025.
Passed the House of Representatives the 3rd day of March, 2025.

Presiding Officer of the House
of Representatives

Passed the Senate the _____ day of __________, 2025.

Presiding Officer of the Senate